跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,458 条关于
“CMP-SYNGAP-01”
全部
6,458
临床试验
3,290
药物
1,885
机构
156
资讯
1,127
11个月前
CAMP4 Therapeutics Advances SYNGAP1 Gene Therapy Toward Clinical Testing with GLP Toxicology Studies
去年
CAMP4 Therapeutics Secures $100 Million Financing to Advance First-in-Class SYNGAP1 Treatment
9个月前
AtaiBeckley Secures Key U.S. Patent for EMP-01 Psychedelic Therapy, Extending Exclusivity Through 2043
去年
Kiromic BioPharma's Deltacel Shows Promise in NSCLC Trial, Moves to Dose Expansion
去年
Breakthrough Humanized Antibody VX-01 Shows Promise Against Deadly Mucormycosis
去年
Relmada Therapeutics Secures Licensing for Novel Bladder Cancer Treatment NDV-01
前天
Avacta Reports Clinical Proof of Mechanism for FAP-Activated Exatecan PDC AVA6103 in Phase 1 FOCUS-01
去年
SKYSCRAPER-01: Tiragolumab Plus Atezolizumab Fails to Improve Overall Survival in PD-L1-High NSCLC
2年前
Greenwich LifeSciences' Flamingo-01 Trial Expands into Europe and Broadens Patient Enrollment
去年
FDA Fast-Tracks Novel Drug PP-01 for Cannabis Withdrawal Syndrome Treatment
第 1 页,共 113 页
上一页
下一页